Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

Camu, W., Mickunas, M., Veyrune, J.-L. et al. (18 more authors) (2020) Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 102844. ISSN 2352-3964

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: Amyotrophic lateral sclerosis; Randomised clinical trial; Low dose interleukin-2; Neuro-inflammation; Biomarkers; Regulatory T cells
Dates:
  • Published (online): 7 July 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
EUROPEAN COMMISSION - HORIZON 2020633413
Depositing User: Symplectic Sheffield
Date Deposited: 27 Jul 2020 13:00
Last Modified: 27 Jul 2020 13:00
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published online
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ebiom.2020.102844
Related URLs:

Share / Export

Statistics